These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38804816)
1. RETRACTION: Six2 Promotes Non-Small Cell Lung Cancer Cell Stemness Via Transcriptionally and Epigenetically Regulating E-Cadherin. Cell Prolif; 2024 Jul; 57(7):e13682. PubMed ID: 38804816 [TBL] [Abstract][Full Text] [Related]
2. Retraction statement: Long noncoding RNA MALAT1 promotes the stemness of esophageal squamous cell carcinoma by enhancing YAP transcriptional activity. FEBS Open Bio, 9: 1392-1402. FEBS Open Bio; 2023 Nov; 13(11):2158. PubMed ID: 37792303 [TBL] [Abstract][Full Text] [Related]
3. Retraction statement: Yiwen Xiao, Jingjing Pan, Qian Geng, Ge Wang (2019), LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability. FEBS Open Bio, 9: 1212-1222. FEBS Open Bio; 2023 Sep; 13(10):1986. PubMed ID: 37724913 [TBL] [Abstract][Full Text] [Related]
4. RETRACTION: Long Non-Coding RNA CRNDE Sponges miR-384 to Promote Proliferation and Metastasis of Pancreatic Cancer Cells through Upregulating IRS1. Cell Prolif; 2024 Aug; 57(8):e13690. PubMed ID: 38853619 [TBL] [Abstract][Full Text] [Related]
5. Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197. FEBS Open Bio; 2023 Aug; 13(8):1540. PubMed ID: 37410095 [TBL] [Abstract][Full Text] [Related]
6. Retraction statement: Wu, H., He, Y., Chen, H., Liu, Y., Wei, B., Chen, G., Lin, H. and Lin, H. (2019), LncRNA THOR increases osteosarcoma cell stemness and migration by enhancing SOX9 mRNA stability. FEBS Open Bio, 9: 781-790. FEBS Open Bio; 2023 Aug; 13(8):1539. PubMed ID: 37219057 [TBL] [Abstract][Full Text] [Related]
9. Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging. J Cell Mol Med; 2024 Aug; 28(15):e18563. PubMed ID: 39087601 [TBL] [Abstract][Full Text] [Related]
10. RETRACTION: MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression. Cell Prolif; 2024 Dec; 57(12):e13767. PubMed ID: 39428107 [TBL] [Abstract][Full Text] [Related]
11. Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206. J Cell Mol Med; 2024 Mar; 28(6):e18199. PubMed ID: 38439141 [TBL] [Abstract][Full Text] [Related]
12. Retraction: Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo. FEBS Open Bio; 2024 Mar; 14(3):528. PubMed ID: 38149473 [TBL] [Abstract][Full Text] [Related]
13. Retraction statement: Shao, L., Zhang, X. and Yao, Q. (2020), The F-box protein FBXO11 restrains hepatocellular carcinoma stemness via promotion of ubiquitin-mediated degradation of Snail. FEBS Open Bio, 10: 1810-1820. FEBS Open Bio; 2023 Aug; 13(8):1537. PubMed ID: 37219054 [TBL] [Abstract][Full Text] [Related]
14. Retraction: lncRNA ABHD11-AS1, regulated by the EGFR pathway, contributes to the ovarian cancer tumorigenesis by epigenetically suppressing TIMP2. Cancer Med; 2024 Mar; 13(5):e7098. PubMed ID: 38470371 [TBL] [Abstract][Full Text] [Related]
15. RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3. J Cell Mol Med; 2024 Aug; 28(15):e18566. PubMed ID: 39109524 [TBL] [Abstract][Full Text] [Related]